AACR logo

More articles from Personalized Medicine and Imaging

MAPK Pathway and TERT Promoter Gene Mutation Pattern and Its Prognostic Value in Melanoma Patients: A Retrospective Study of 2,793 Cases
Xue Bai, Yan Kong, Zhihong Chi, Xinan Sheng, Chuanliang Cui, Xuan Wang, Lili Mao, Bixia Tang, Siming Li, Bin Lian, Xieqiao Yan, Li Zhou, Jie Dai, Jun Guo, Lu Si

Clinical Cancer Research Oct 2017, 23 (20) 6120-6127; DOI: 10.1158/1078-0432.CCR-17-0980
Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients
Jie Sun, Hua Meng, Lu Yao, Meng Lv, Jian Bai, Jianguang Zhang, Lientu Wang, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, Yuntao Xie

Clinical Cancer Research Oct 2017, 23 (20) 6113-6119; DOI: 10.1158/1078-0432.CCR-16-3227
⁸⁹Zr-Lumretuzumab PET Imaging before and during HER3 Antibody Lumretuzumab Treatment in Patients with Solid Tumors
Frederike Bensch, Laetitia E. Lamberts, Michaël M. Smeenk, Annelies Jorritsma-Smit, Marjolijn N. Lub-de Hooge, Anton G.T. Terwisscha van Scheltinga, Johan R. de Jong, Jourik A. Gietema, Carolien P. Schröder, Marlene Thomas, Wolfgang Jacob, Keelara Abiraj, Celine Adessi, Georgina Meneses-Lorente, Ian James, Martin Weisser, Adrienne H. Brouwers, Elisabeth G.E. de Vries

Clinical Cancer Research Oct 2017, 23 (20) 6128-6137; DOI: 10.1158/1078-0432.CCR-17-0311
Detection of Activating Estrogen Receptor Gene (ESR1) Mutations in Single Circulating Tumor Cells
Carmela Paolillo, Zhaomei Mu, Giovanna Rossi, Matthew J. Schiewer, Thomas Nguyen, Laura Austin, Ettore Capoluongo, Karen Knudsen, Massimo Cristofanilli, Paolo Fortina

Clinical Cancer Research Oct 2017, 23 (20) 6086-6093; DOI: 10.1158/1078-0432.CCR-17-1173
Molecular Screening for Cancer Treatment Optimization (MOSCATO-01) in Pediatric Patients: A Single-Institutional Prospective Molecular Stratification Trial
Anne C. Harttrampf, Ludovic Lacroix, Marc Deloger, Frederic Deschamps, Stephanie Puget, Nathalie Auger, Philippe Vielh, Pascale Varlet, Zsofia Balogh, Samuel Abbou, Adrien Allorant, Dominique Valteau-Couanet, Sabine Sarnacki, Louise Gamiche-Rolland, Guillaume Meurice, Veronique Minard-Colin, Jacques Grill, Laurence Brugieres, Christelle Dufour, Nathalie Gaspar, Stefan Michiels, Gilles Vassal, Jean-Charles Soria, Birgit Geoerger

Clinical Cancer Research Oct 2017, 23 (20) 6101-6112; DOI: 10.1158/1078-0432.CCR-17-0381
Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype
Maeve A. Lowery, Emmet J. Jordan, Olca Basturk, Ryan N. Ptashkin, Ahmet Zehir, Michael F. Berger, Tanisha Leach, Brian Herbst, Gokce Askan, Hannah Maynard, Danielle Glassman, Christina Covington, Nikolaus Schultz, Ghassan K. Abou-Alfa, James J. Harding, David S. Klimstra, Jaclyn F. Hechtman, David M. Hyman, Peter J. Allen, William R. Jarnagin, Vinod P. Balachandran, Anna M. Varghese, Mark A. Schattner, Kenneth H. Yu, Leonard B. Saltz, David B. Solit, Christine A. Iacobuzio-Donahue, Steven D. Leach, Eileen M. O'Reilly

Clinical Cancer Research Oct 2017, 23 (20) 6094-6100; DOI: 10.1158/1078-0432.CCR-17-0899
Hypermutated Circulating Tumor DNA: Correlation with Response to Checkpoint Inhibitor–Based Immunotherapy
Yulian Khagi, Aaron M. Goodman, Gregory A. Daniels, Sandip P. Patel, Assuntina G. Sacco, James M. Randall, Lyudmila A. Bazhenova, Razelle Kurzrock

Clinical Cancer Research Oct 2017, 23 (19) 5729-5736; DOI: 10.1158/1078-0432.CCR-17-1439
Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer
M. Eileen Dolan, Omar El Charif, Heather E. Wheeler, Eric R. Gamazon, Shirin Ardeshir-Rouhani-Fard, Patrick Monahan, Darren R. Feldman, Robert J. Hamilton, David J. Vaughn, Clair J. Beard, Chunkit Fung, Jeri Kim, Sophie D. Fossa, Daniel L Hertz, Taisei Mushiroda, Michiaki Kubo, Lawrence H. Einhorn, Nancy J. Cox, Lois B. Travis for the Platinum Study Group

Clinical Cancer Research Oct 2017, 23 (19) 5757-5768; DOI: 10.1158/1078-0432.CCR-16-3224
Tumor Response Dynamics of Advanced Non–small Cell Lung Cancer Patients Treated with PD-1 Inhibitors: Imaging Markers for Treatment Outcome
Mizuki Nishino, Suzanne E. Dahlberg, Anika E. Adeni, Christine A. Lydon, Hiroto Hatabu, Pasi A. Jänne, F. Stephen Hodi, Mark M. Awad

Clinical Cancer Research Oct 2017, 23 (19) 5737-5744; DOI: 10.1158/1078-0432.CCR-17-1434
Diffusion MRI Phenotypes Predict Overall Survival Benefit from Anti-VEGF Monotherapy in Recurrent Glioblastoma: Converging Evidence from Phase II Trials
Benjamin M. Ellingson, Elizabeth R. Gerstner, Marion Smits, Raymond Y. Huang, Rivka Colen, Lauren E. Abrey, Dana T. Aftab, Gisela M. Schwab, Colin Hessel, Robert J. Harris, Ararat Chakhoyan, Renske Gahrmann, Whitney B. Pope, Kevin Leu, Catalina Raymond, Davis C. Woodworth, John de Groot, Patrick Y. Wen, Tracy T. Batchelor, Martin J. van den Bent, Timothy F. Cloughesy

Clinical Cancer Research Oct 2017, 23 (19) 5745-5756; DOI: 10.1158/1078-0432.CCR-16-2844

Main menu

User menu

Search

More articles from Personalized Medicine and Imaging

Pages

Articles

Info for

About Clinical Cancer Research